Pergoveris is a fertility medication used to stimulate ovulation in women who are undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF). It contains two active substances, follitropin alfa and lutropin alfa, which are synthetic versions of the natural hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), respectively. These hormones play key roles in the reproductive process, with FSH being crucial for the growth and development of ovarian follicles, and LH being important for ovulation and the maintenance of the corpus luteum. Pergoveris is administered through subcutaneous injections, and its use is typically supervised by a healthcare professional specializing in fertility treatments. The combination of FSH and LH in Pergoveris helps stimulate the ovaries to produce multiple follicles, increasing the chances of successful egg retrieval and fertilization in ART procedures.